Cempra Inc. (NASDAQ:CEMP)’s share price was down 4.1% during mid-day trading on Thursday . The company traded as low as $17.58 and last traded at $17.63, with a volume of 517,019 shares traded. The stock had previously closed at $18.39.

A number of equities analysts recently issued reports on CEMP shares. Cowen and Company restated a “buy” rating on shares of Cempra in a report on Friday, June 24th. Needham & Company LLC restated a “buy” rating and issued a $48.00 target price on shares of Cempra in a report on Friday, June 24th. Stifel Nicolaus decreased their target price on Cempra from $51.00 to $47.00 and set a “buy” rating on the stock in a report on Friday, June 24th. Roth Capital started coverage on Cempra in a report on Tuesday, June 7th. They issued a “buy” rating and a $37.00 target price on the stock. Finally, Jefferies Group restated a “buy” rating on shares of Cempra in a report on Sunday, May 29th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $36.27.

The stock’s 50 day moving average price is $17.92 and its 200-day moving average price is $17.60. The stock’s market capitalization is $866.15 million.

Cempra (NASDAQ:CEMP) last posted its quarterly earnings data on Monday, May 2nd. The company reported ($0.61) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.63) by $0.02. The firm had revenue of $2.70 million for the quarter, compared to analyst estimates of $3.94 million. During the same period in the prior year, the company posted ($0.41) EPS. The firm’s quarterly revenue was down 80.7% compared to the same quarter last year. Equities analysts forecast that Cempra Inc. will post ($2.58) EPS for the current year.

Other hedge funds and institutional investors have recently bought and sold shares of the company. California Public Employees Retirement System increased its position in Cempra by 427.9% in the fourth quarter. California Public Employees Retirement System now owns 117,200 shares of the company’s stock valued at $3,648,000 after buying an additional 95,000 shares in the last quarter. ProShare Advisors LLC increased its position in Cempra by 9.6% in the fourth quarter. ProShare Advisors LLC now owns 39,993 shares of the company’s stock valued at $1,245,000 after buying an additional 3,490 shares in the last quarter. Gabelli Funds LLC increased its position in Cempra by 19.7% in the fourth quarter. Gabelli Funds LLC now owns 93,509 shares of the company’s stock valued at $2,911,000 after buying an additional 15,409 shares in the last quarter. Finally, Wells Fargo & Company MN increased its position in Cempra by 14.2% in the fourth quarter. Wells Fargo & Company MN now owns 307,113 shares of the company’s stock valued at $9,561,000 after buying an additional 38,204 shares in the last quarter.

Cempra, Inc is a clinical-stage pharmaceutical company. The Company is focused on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic staphylococcal infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.